Search
Patexia Interest Groups

Pharma > Nova Content

Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and... Read More »
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and... Read More »
BeiGene, a biotechnology company, has taken legal action by filing patent infringement lawsuits against pharmaceutical companies Sandoz... Read More »
Shares of UroGen Pharma (NASDAQ: URGN) took a minor premarket hit following news that Teva Pharmaceutical (NYSE: TEVA) has submitted an... Read More »
  The Biden administration is exploring the use of "march-in" rights established in the 1980 Bayh-Dole Act, which... Read More »
In August, our much-anticipated fourth annual ANDA Litigation Intelligence Report made its entrance into the world of pharmaceutical litigation... Read More »
    In a groundbreaking legal development, Eli Lilly has secured a remarkable victory in a high-stakes patent... Read More »
    In the intricate world of pharmaceuticals, where innovation meets regulation, ANDA litigation stands as a... Read More »
In the realm of pharmaceuticals, the approval process for generic and brand-name drugs holds significant importance. The Hatch-Waxman Act, ... Read More »
    British drugmaker GlaxoSmithKline (GSK) has taken American pharmaceutical giant Pfizer to court, alleging a... Read More »
    When it comes to generic medications, the Abbreviated New Drug Application (ANDA) process plays a crucial... Read More »
The landscape of patent litigation is ever-evolving, and the first half of 2023 has been no exception. The dynamics of patent litigation are... Read More »
When it comes to preparing an Abbreviated New Drug Application (ANDA), there are several common pitfalls that applicants often encounter... Read More »
The Abbreviated New Drug Application (ANDA) process plays a vital role in the pharmaceutical industry, enabling generic drug manufacturers ... Read More »
Promosome LLC, a biotech firm represented by law firm Susman Godfrey, has just filed a patent infringement lawsuits against Moderna... Read More »
The Hatch-Waxman Act, officially known as the Drug Price Competition and Patent Term Restoration Act, revolutionized the pharmaceutical... Read More »
In the world of pharmaceuticals, the Abbreviated New Drug Application (ANDA) process plays a critical role in the approval and market... Read More »
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More »
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in ... Read More »
Menu